<SEC-DOCUMENT>0001279569-20-000062.txt : 20200117
<SEC-HEADER>0001279569-20-000062.hdr.sgml : 20200117
<ACCEPTANCE-DATETIME>20200117081134
ACCESSION NUMBER:		0001279569-20-000062
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200117
FILED AS OF DATE:		20200117
DATE AS OF CHANGE:		20200117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Canopy Growth Corp
		CENTRAL INDEX KEY:			0001737927
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38496
		FILM NUMBER:		20532297

	BUSINESS ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
		BUSINESS PHONE:		855-558-9333

	MAIL ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>canopy6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD></HEAD>
<TITLE></TITLE>
<body>


<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"></P>

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 30%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 6-K</B></P>



<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 30%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNDER THE SECURITIES EXCHANGE ACT
OF 1934</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">For the month of January
2020.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Commission File Number 001-38496</P>



<P STYLE="font: 20pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 30%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 20pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Canopy Growth Corporation</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(Translation of registrant&rsquo;s name
into English)&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 30%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>1 Hershey Drive</B></P>

<P STYLE="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Smiths Falls, Ontario</B></P>

<P STYLE="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>K7A 0A8</B></P>

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive office)</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 30%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 12pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-For Form 40-F:</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Form 20-F </FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Form 40-F </FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9746;</FONT></P>

<P STYLE="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 12pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): </FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0"><B>Note</B>: Regulation S-T Rule 101(b)(1) only permits
the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</P>

<P STYLE="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 12pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): </FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0"><B>Note</B>: Regulation S-T Rule 101(b)(7) only permits
the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer
must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized
(the registrant&rsquo;s &ldquo;home country&rdquo;), or under the rules of the home country exchange on which the registrant&rsquo;s
securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed
to the registrant&rsquo;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission
or other Commission filing on EDGAR.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0"></P>




<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 0.75pt"><DIV STYLE="font-size: 1pt; border-top: gray 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Exhibit Index</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 86%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">
        <P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 1pt solid"><B>&nbsp;&nbsp;&nbsp;&nbsp;Exhibit&nbsp;No.&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
    <TD STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">
        <P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0; border-bottom: black 1pt solid; margin-bottom: 0; text-align: center"><B>&nbsp;&nbsp;&nbsp;&nbsp;Description&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex991.htm">Ex. 99.1</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex991.htm">News
    Release dated January 17, 2020 - Canopy Growth Revises Beverage Launch Timeline</A> </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0.25in 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/0.05pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 0.75pt"><DIV STYLE="font-size: 1pt; border-top: gray 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 11.25pt 0 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 8pt">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="width: 50%; border-collapse: collapse">
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif; padding-right: 2.8pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif; padding-right: 2.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CANOPY GROWTH CORPORATION</B></FONT></TD>
    <TD STYLE="padding-bottom: 8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 11%; padding-right: 0.8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; padding-right: 0.8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 77%">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; border-bottom: black 0.75pt solid">/s/ Phil Shaer</P></TD>
    <TD STYLE="padding-bottom: 8pt; width: 11%; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0">Phil Shaer</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0">Chief Legal Officer</P></TD>
    <TD STYLE="padding-bottom: 8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
</TABLE><BR STYLE="clear: both">
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Dated: January 17, 2020</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED JANUARY 17, 2020
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth Revises Beverage Launch
Timeline</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SMITHS FALLS, ON, Jan. 17, 2020 /CNW/ -&nbsp;Canopy
Growth Corporation (&quot;Canopy Growth&quot; or the &quot;Company&quot;) (TSX: WEED), (NYSE: CGC) submitted its final documentation
for its beverage facility to Health Canada in late June 2019 and subsequently received the licence in late November 2019. In the
seven weeks since receiving the licence, the Company has made meaningful progress&nbsp;towards scaling the production process for
its cannabis beverages from lab scale to commercial scale.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Management remains very confident in the underlying
beverage science and in its ability to scale production and deliver high quality, differentiated cannabis beverages to the market.
However, the scaling process is not complete, and the Company is extending its to-market date while the internal teams complete
the final steps.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;Canopy has had seven weeks to work with
THC in the brand new beverage facility to scale processes and IP it has developed in the R&amp;D environment,&quot; said David
Klein, CEO, Canopy Growth. &quot;In order to deliver products that meet our customer's high standards we are electing to revise
the launch date while we work through the final details.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Cannabis beverages have disruptive power and
in time, may introduce new consumers to the cannabis category. Canopy does not believe this delay will have a material impact&nbsp;on
its&nbsp;FY20 revenue.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The Company intends to provide an update with
the release of its Q3 FY20 financial results.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Here's to Future (Cannabis Category) Growth.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Canopy Growth Corporation<BR>
</B>Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct
brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth's
subsidiary, Storz &amp; Bickel GMbH &amp; Co. KG. From product and process innovation to market execution, Canopy Growth is driven
by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.
Canopy Growth has operations in over a dozen countries across five continents.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth's medical division, Spectrum
Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the
public's understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development.
Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as
single cannabinoid Dronabinol under the brand Bionorica Ethics.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth operates retail stores across
Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large
and loyal following by focusing on quality products and meaningful customer relationships.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">From our historic public listing on the Toronto
Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through
leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including
cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation
Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet
of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Notice Regarding Forward Looking Statements<BR>
</B>This news release contains &quot;forward-looking statements&quot; within the meaning of the United States Private Securities
Litigation Reform Act of 1995 and &quot;forward-looking information&quot; within the meaning of applicable Canadian securities
legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as &quot;plans&quot;,
&quot;expects&quot; or &quot;does not expect&quot;, &quot;is expected&quot;, &quot;estimates&quot;, &quot;intends&quot;, &quot;anticipates&quot;
or &quot;does not anticipate&quot;, or &quot;believes&quot;, or variations of such words and phrases or state that certain actions,
events or results &quot;may&quot;, &quot;could&quot;, &quot;would&quot;, &quot;might&quot; or &quot;will&quot; be taken, occur
or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which
may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from
any future results, performance or achievements expressed or implied by the forward-looking statements or information contained
in this news release. Examples of such statements include statements with respect to future product format offerings. Risks, uncertainties
and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities
to differ materially from those expressed or implied by such forward-looking information, including the Company's ability to satisfy
provincial sales contracts or provinces purchasing all cannabis allocated to them, and such risks contained in the Company's annual
information form dated June 25, 2019 and filed with Canadian securities regulators available on the Company's issuer profile on
SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information
or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and
no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and
forward-looking statements included in this news release are made as of the date of this news release and the Company does not
undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information,
subsequent events or otherwise unless required by applicable securities laws.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-growth-revises-beverage-launch-timeline-300988844.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SOURCE Canopy Growth Corporation</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:
http://www.newswire.ca/en/releases/archive/January2020/17/c6345.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">%CIK: 0001737927</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information: </B>Kyna Boyce, Media Relations, Kyna.boyce@canopygrowth.com,
613-485-2480; Tyler Burns, Vice President, Investor Relations, Tyler.Burns@canopygrowth.com, 855-558-9333 ext. 122</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CO: Canopy Growth Corporation</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CNW 07:11e 17-JAN-20</P>



<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>



<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>



<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></p>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" "0 -L# 2(  A$! Q$!_\0
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H<L;*/3[2.VA+>7&,+N.3^=3XQ2T +1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
